Evoq Remedies — 360° view

Evoq Remedies, a company in the Trading & Distributors industry, reported revenue of ₹26 crore and net profit of ₹0.05 crore for the September 2025 quarter.

Evoq Remedies (BSE: EVOQ) closed at ₹1.79 on 20 Nov 2026, down 52.1% over the past year. Its market capitalisation is ₹4 crore.

Share price
₹1.79 (20 Nov 2026)
Market cap
₹4 Cr (20 Nov 2026)
Revenue
₹26 Cr (September 2025 quarter)
Net profit
₹0 Cr (September 2025 quarter)
ROCE
-0.56% (FY26)
ROE
-0.54% (FY26)
Book value
₹17.8 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹4.20 / ₹1.35 (20 Nov 2026)
1-year return
-52.1% (to 20 Nov 2026)
Sector
Services
Industry
Trading & Distributors
Symbol
BSE: EVOQ

Incorporated in 2010, EVOQ Remedies Ltd is in the pharmaceutical business.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.